Dr. Anita Shah joined Renal Specialists of Houston in 2020 after completing a fellowship in Nephrology at Baylor College of Medicine. Recognized as Baylor Nephrology’s Educator of the Year in 2019 with an impressive record of publications and presentations, she brings her expertise to the care of kidney patients. Dr. Shah practices predominantly in our Medical Center and Sugar Land locations and serves as Medical Director of Fresenius Kidney Care Southeast.
PROFESSIONAL/ACADEMIC
- Clinical and Transplant Nephrologist, Baylor St. Luke’s Medical Center and Houston Methodist Hospital, 2020 - current
- Private Instructor, PSU Know How, State College PA, 2010 – 2011
RENAL FELLOWSHIP
- Baylor College of Medicine, Houston TX 2018 – 2020
RESIDENCY
- Houston Methodist Hospital, Houston TX 2015-2018
MEDICAL SCHOOL
- University of Texas Medical Branch, Galveston TX 2011 – 2015
BOARD CERTIFICATION
- American Board of Internal Medicine
- American Board of Internal Medicine, Diplomate in Nephrology
AREAS OF CLINICAL INTEREST
- Renal Transplantation
- Acute Kidney Injury
- Chronic Kidney Disease
AWARDS/HONORS
- Baylor College of Medicine Nephrology Department’s 2018-2019 Educator of the Year
MEDICAL ASSOCIATIONS
- American Society of Nephrology
- Gold Humanism Honor Society
PUBLICATIONS
- Shah A, Navaneethan S. Novel therapeutic options for management of electrolyte disorders. Curr Opin Nephrol Hypertension 2019; 28(5): 407-08.
- Shah A, Olivero JJ. Lipids and renal disease. Methodist Debakey Cardiovasc J. 2019; 15(1): 88-89.
- Shah A. What happens on dialysis is likely from dialysis: Tunneled dialysis catheter infections. Renal Fellow Network. October 21, 2018..
- Shah A, Olivero JJ. Gadolinium-induced nephrogenic systemic fibrosis. Methodist Debakey Cardiovasc J. 2017; 13(3): 172-73
RESEARCH
- Principal Investigator, Baylor College of Medicine. Improving serum albumin in peritoneal dialysis patients. 2019 – 2020.
- Principal Investigator, Houston Methodist Hospital. Risk factors associated with focal glomerulosclerosis recurrence in renal transplant patients. 2016 – 2018.
- Principal Investigator. University of Texas Medical Branch. The nature of testosterone and vitamin D in lung transplantation. 2012 - 2015
PRESENTATIONS
- Shah A, Shah M. Abiraterone acetate-Enough of the S.A.M.E. old steroids. American Society of Nephrology Kidney Week Washington DC 2019
- Shah A, Shah M, Ramanathan V. Simultaneous acute rejection and recurrent focal segmental glomerulosclerosis: A match made in renal transplantation. American Society of Nephrology Kidney Week Washington DC 2019
- Shah A, Gonzalez J. Risk factors associated with focal segmental glomerulosclerosis (FSGS) recurrence in renal transplant patients. Texas Chapter Annual Meeting San Antonio, TX 2017
- Jain A, Shah A, Jackson R. It indeed hit a new low! Texas Chapter ACP Associates’ Day Houston, TX 2017
- Memon H, Shah A, Awar M. ST elevation MI or thymoma? American College of Physicians’ Internal Medicine Conference; Washington, DC 2016
- Memon H, Shah A, Awar M. ST elevation MI or thymoma? Texas Chapter ACP Associates’ Day; Houston, TX 2016
- Shah A, Valentine V. The nature of testosterone and vitamin d in lung transplantation. 55th Annual National Student Research Forum; Galveston TX 2014
- Shah A, Valentine V. The nature of testosterone and vitamin d in lung transplantation. 99th Annual American Medical Women’s Association’s Conference; Washington, DC 2014
- Shah A, Valentine V. The nature of testosterone and vitamin d in lung transplantation. American College of Physicians’ Internal Medicine Conference; San Francisco, CA 2013
- Shah A, Valentine V. The nature of testosterone and vitamin d in lung transplantation. Poster presentation at: UTMB’s Medical Student Summer Research Program; Galveston, TX 2012.
